Canadian Journal of Gastroenterology and Hepatology

Table of Contents: 2003

  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 462148

Ethical Issues in the Management of Helicobacter pylori Infection

Anthony Axon
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 585862

Can the Response to Eradication Therapy in Helicobacter pylori Infection be Predicted?

Robert Clancy | Thomas Borody | ... | Gerald Pang
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 241508

What Constitutes Failure for Helicobacter pylori Eradication Therapy?

P Malfertheiner | U Peitz | G Treiber
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 704035

Helicobacter pylori Resistance to Antibiotics: Prevalence, Mechanism, Detection. What’s New?

Francis Mégraud
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 567816

What is the Helicobacter pylori Global Reinfection Rate?

Julie Parsonnet
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 136716

Eradication Therapy Should Be Different for Dyspeptic Patients than for Ulcer Patients

Wink A de Boer
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 714124

How Can the Current Strategies for Helicobacter pylori Eradication Therapy be Improved?

Alex Ford | Paul Moayyedi
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 303528

Is It Time for Quadruple Therapy to be First Line?

Loren Laine
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 903494

Are There Geographical and Regional Differences in Helicobacter pylori Eradication?

Nimish Vakil
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 720743

What are the Global Response Rates to Helicobacter pylori Eradication Therapy?

Christopher Nash | Lori Fischbach | Sander Veldhuyzen van Zanten
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 401397

Helicobacter pylori Management: How to Improve the Therapeutic Confusion in Practice

Nicholas J Talley
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 692808

The Evolving Epidemiology of Helicobacter pylori Infection and Gastric Cancer

Jia-Qing Huang | Richard H Hunt
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 350347

Role of Bacterial Overgrowth in the Stomach as an Additional Risk Factor for Gastritis

Gregory Naylor | Anthony Axon
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 397060

The Role of Interleukin-1Beta and Other Potential Genetic Markers as Indicators of Gastric Cancer Risk

Esther Troost | Georgina L Hold | ... | Emad M El-Omar
  • Canadian Journal of Gastroenterology and Hepatology -
  • Special Issue
  • Volume 17
  • - Article ID 963927

Helicobacter pylori Twenty Years on...

Richard H Hunt
Canadian Journal of Gastroenterology and Hepatology
 Journal metrics
Acceptance rate26%
Submission to final decision79 days
Acceptance to publication42 days
CiteScore2.800
Impact Factor2.055
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.